HomeCompareMDCLF vs STAG

MDCLF vs STAG: Dividend Comparison 2026

MDCLF yields 5.82% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDCLF wins by $11.0K in total portfolio value
10 years
MDCLF
MDCLF
● Live price
5.82%
Share price
$34.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$842.73
Full MDCLF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — MDCLF vs STAG

📍 MDCLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDCLFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDCLF + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDCLF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDCLF
Annual income on $10K today (after 15% tax)
$494.33/yr
After 10yr DRIP, annual income (after tax)
$716.32/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, MDCLF beats the other by $323.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDCLF + STAG for your $10,000?

MDCLF: 50%STAG: 50%
100% STAG50/50100% MDCLF
Portfolio after 10yr
$23.8K
Annual income
$652.47/yr
Blended yield
2.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

MDCLF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
5.5
Piotroski
5/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDCLF buys
0
STAG buys
0
No recent congressional trades found for MDCLF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDCLFSTAG
Forward yield5.82%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$29.3K$18.3K
Annual income after 10y$842.73$462.22
Total dividends collected$7.2K$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: MDCLF vs STAG ($10,000, DRIP)

YearMDCLF PortfolioMDCLF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$11,282$581.56$10,665$345.09+$617.00MDCLF
2$12,684$613.17$11,364$357.70+$1.3KMDCLF
3$14,217$644.32$12,098$370.43+$2.1KMDCLF
4$15,887$674.91$12,869$383.28+$3.0KMDCLF
5$17,704$704.85$13,677$396.23+$4.0KMDCLF
6$19,677$734.08$14,524$409.27+$5.2KMDCLF
7$21,817$762.53$15,411$422.41+$6.4KMDCLF
8$24,134$790.14$16,339$435.61+$7.8KMDCLF
9$26,641$816.89$17,311$448.89+$9.3KMDCLF
10$29,348$842.73$18,327$462.22+$11.0KMDCLF

MDCLF vs STAG: Complete Analysis 2026

MDCLFStock

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France.

Full MDCLF Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this MDCLF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDCLF vs SCHDMDCLF vs JEPIMDCLF vs OMDCLF vs KOMDCLF vs MAINMDCLF vs PLDMDCLF vs EQRMDCLF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.